GRI-003

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameGRI-003
Drug Alias NameGRI-003
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionImmunomodulatorsNatural killer T-lymphocyte stimulants
TargetsUpdating
Therapy Area/IndicationsFatty Liver, Alcoholic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGri Bio Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGri Bio Inc
Active IndicationsN/A
Inactive IndicationsFatty Liver, Alcoholic

Other Information

ATC CodeN/A
Related LinksN/A